D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia

Kevin N. Boyd, Richard B. Mailman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
Original languageEnglish (US)
Title of host publicationTargets and Emerging Therapies for Schizophrenia
PublisherJohn Wiley and Sons
Pages51-84
Number of pages34
ISBN (Print)9780470322826
DOIs
StatePublished - Jun 24 2012

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Boyd, K. N., & Mailman, R. B. (2012). D1/D5 Dopamine Agonists as Pharmacotherapy for Schizophrenia. In Targets and Emerging Therapies for Schizophrenia (pp. 51-84). John Wiley and Sons. https://doi.org/10.1002/9781118309421.ch3